Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Equity (2018 - 2025)

Dna X (SONM) has disclosed Return on Equity for 8 consecutive years, with 33.44% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 3426.0% year-over-year to 33.44%, compared with a TTM value of 33.44% through Sep 2025, up 3426.0%, and an annual FY2024 reading of 4.11%, down 411.0% over the prior year.
  • Return on Equity was 33.44% for Q3 2025 at Dna X, up from 26.35% in the prior quarter.
  • Across five years, Return on Equity topped out at 33.44% in Q3 2025 and bottomed at 7.11% in Q4 2024.
  • Average Return on Equity over 5 years is 2.4%, with a median of 0.55% recorded in 2024.
  • The sharpest move saw Return on Equity tumbled -710bps in 2024, then skyrocketed 3426bps in 2025.
  • Year by year, Return on Equity stood at 2.47% in 2021, then surged by 100bps to 0.01% in 2022, then soared by 60bps to 0.0% in 2023, then crashed by -179495bps to 7.11% in 2024, then surged by 571bps to 33.44% in 2025.
  • Business Quant data shows Return on Equity for SONM at 33.44% in Q3 2025, 26.35% in Q2 2025, and 9.13% in Q1 2025.